ULTRAGENYX PHARMACEUTICAL INC. Basic Shares Outstanding (Weighted Average)
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Basic Shares Outstanding (Weighted Average) of 101.90 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 101.90M shares, a 3.45% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 100.60M shares, a 4.47% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 99.84M shares, a 4.47% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 99.77M shares, a 4.48% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for fiscal 2025 was 98.60M shares, a 8.95% increase from fiscal 2024.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for fiscal 2024 was 90.50M shares, a 23.13% increase from fiscal 2023.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for fiscal 2023 was 73.50M shares, a 5.13% increase from fiscal 2022.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic for fiscal 2022 was 69.91M shares, a 3.13% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 101.90M shares 10-Q · filed 2026-08-05 | 101.30M shares 10-Q · filed 2026-08-05 | 100.78M shares derived: average of 3 quarters · filed 2026-08-05 | 100.53M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | 100.60M shares 10-Q · filed 2026-05-06 | 100.22M shares derived: average of 2 quarters · filed 2026-05-06 | 100.07M shares derived: average of 3 quarters · filed 2026-05-06 | 99.68M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | 99.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | 99.81M shares derived: average of 2 quarters · filed 2026-02-18 | 99.37M shares derived: average of 3 quarters · filed 2026-08-05 | 98.60M shares 10-K · filed 2026-02-18 | |||
| 2025-09-30 | 99.77M shares 10-Q · filed 2025-11-05 | 99.14M shares derived: average of 2 quarters · filed 2026-08-05 | 98.19M shares 10-Q · filed 2025-11-05 | 97.53M shares derived: average of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | 98.50M shares 10-Q · filed 2026-08-05 | 98.46M shares 10-Q · filed 2025-08-06 | 97.40M shares 10-Q · filed 2026-08-05 | 97.38M shares 10-Q · filed 2025-08-06 | 96.79M shares derived: average of 3 quarters · filed 2026-08-05 | 96.47M shares derived: average of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | 96.30M shares 10-Q · filed 2026-05-06 | 96.29M shares 10-Q · filed 2025-05-07 | 95.93M shares derived: average of 2 quarters · filed 2026-05-06 | 95.79M shares derived: average of 3 quarters · filed 2026-05-06 | 93.49M shares derived: average of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | 95.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | 95.53M shares derived: average of 2 quarters · filed 2026-02-18 | 92.55M shares derived: average of 3 quarters · filed 2026-02-18 | 90.50M shares 10-K · filed 2026-02-18 | 90.54M shares 10-K · filed 2025-02-19 | ||
| 2024-09-30 | 95.49M shares 10-Q · filed 2025-11-05 | 91.04M shares derived: average of 2 quarters · filed 2025-11-05 | 88.81M shares 10-Q · filed 2025-11-05 | 86.85M shares derived: average of 4 quarters · filed 2026-02-18 | |||
| 2024-06-30 | 86.58M shares 10-Q · filed 2025-08-06 | 85.43M shares 10-Q · filed 2025-08-06 | 83.97M shares derived: average of 3 quarters · filed 2026-02-18 | 80.89M shares derived: average of 4 quarters · filed 2026-02-18 | |||
| 2024-03-31 | 84.29M shares 10-Q · filed 2025-05-07 | 82.66M shares derived: average of 2 quarters · filed 2026-02-18 | 79.00M shares derived: average of 3 quarters · filed 2026-02-18 | 76.97M shares derived: average of 4 quarters · filed 2026-02-18 | |||
| 2023-12-31 | 81.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | 76.35M shares derived: average of 2 quarters · filed 2026-02-18 | 74.53M shares derived: average of 3 quarters · filed 2026-02-18 | 73.50M shares 10-K · filed 2026-02-18 | 73.54M shares 10-K · filed 2024-02-21 | ||
| 2023-09-30 | 71.66M shares 10-Q · filed 2024-11-06 | 71.28M shares derived: average of 2 quarters · filed 2024-11-06 | 70.99M shares 10-Q · filed 2024-11-06 | 70.77M shares derived: average of 4 quarters · filed 2025-02-19 | |||
| 2023-06-30 | 70.90M shares 10-Q · filed 2024-08-02 | 70.64M shares 10-Q · filed 2024-08-02 | 70.47M shares derived: average of 3 quarters · filed 2025-02-19 | 70.37M shares derived: average of 4 quarters · filed 2025-02-19 | |||
| 2023-03-31 | 70.37M shares 10-Q · filed 2024-05-03 | 70.26M shares derived: average of 2 quarters · filed 2025-02-19 | 70.19M shares derived: average of 3 quarters · filed 2025-02-19 | 70.13M shares derived: average of 4 quarters · filed 2025-02-19 | |||
| 2022-12-31 | 70.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | 70.10M shares derived: average of 2 quarters · filed 2025-02-19 | 70.04M shares derived: average of 3 quarters · filed 2025-02-19 | 69.91M shares 10-K · filed 2025-02-19 | |||
| 2022-09-30 | 70.05M shares 10-Q · filed 2023-11-03 | 69.99M shares derived: average of 2 quarters · filed 2023-11-03 | 69.83M shares 10-Q · filed 2023-11-03 | 69.52M shares derived: average of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | 69.93M shares 10-Q · filed 2023-08-04 | 69.72M shares 10-Q · filed 2023-08-04 | 69.34M shares derived: average of 3 quarters · filed 2024-02-21 | 68.97M shares derived: average of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | 69.52M shares 10-Q · filed 2023-05-05 | 69.05M shares derived: average of 2 quarters · filed 2024-02-21 | 68.66M shares derived: average of 3 quarters · filed 2024-02-21 | 68.40M shares derived: average of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | 68.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | 68.23M shares derived: average of 2 quarters · filed 2024-02-21 | 68.02M shares derived: average of 3 quarters · filed 2024-02-21 | 67.80M shares 10-K · filed 2024-02-21 | |||
| 2021-09-30 | 67.88M shares 10-Q · filed 2022-11-03 | 67.74M shares derived: average of 2 quarters · filed 2022-11-03 | 67.53M shares 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | 67.61M shares 10-Q · filed 2021-08-03 | 67.36M shares 10-Q · filed 2021-08-03 | |||||
| 2020-12-31 | 60.85M shares 10-K · filed 2023-02-17 | ||||||
| 2020-06-30 | 60.00M shares 10-Q · filed 2021-08-03 | 59.00M shares 10-Q · filed 2021-08-03 | |||||
| 2019-06-30 | 57.52M shares 10-Q · filed 2020-07-30 | 55.38M shares 10-Q · filed 2020-07-30 | |||||
| 2019-03-31 | 53.21M shares 10-Q · filed 2019-05-07 | ||||||
| 2018-03-31 | 48.19M shares 10-Q · filed 2019-05-07 | ||||||
| 2017-03-31 | 41.84M shares 10-Q · filed 2018-05-08 | ||||||
| 2015-12-31 | 36.78M shares 10-K · filed 2016-02-26 | ||||||
| 2015-06-30 | 35.94M shares 10-Q · filed 2015-08-14 | 34.98M shares 10-Q · filed 2015-08-14 | 33.96M shares derived: average of 3 quarters · filed 2016-02-26 | 33.38M shares derived: average of 4 quarters · filed 2016-02-26 | |||
| 2015-03-31 | 34.01M shares 10-Q · filed 2015-05-12 | 32.97M shares derived: average of 2 quarters · filed 2016-02-26 | 32.52M shares derived: average of 3 quarters · filed 2016-02-26 | 31.91M shares derived: average of 4 quarters · filed 2016-02-26 | |||
| 2014-12-31 | 31.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 31.78M shares derived: average of 2 quarters · filed 2016-02-26 | 31.21M shares derived: average of 3 quarters · filed 2016-02-26 | 28.76M shares 10-K · filed 2016-02-26 | |||
| 2014-09-30 | 31.63M shares 10-Q · filed 2014-11-10 | 30.84M shares derived: average of 2 quarters · filed 2015-08-14 | 27.70M shares 10-Q · filed 2014-11-10 | 21.75M shares derived: average of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | 30.06M shares 10-Q · filed 2015-08-14 | 25.70M shares 10-Q · filed 2015-08-14 | 18.46M shares derived: average of 3 quarters · filed 2016-02-26 | 14.75M shares derived: average of 4 quarters · filed 2016-02-26 | |||
| 2014-03-31 | 21.58M shares 10-Q · filed 2015-05-12 | 12.66M shares derived: average of 2 quarters · filed 2016-02-26 | 9.65M shares derived: average of 3 quarters · filed 2016-02-26 | 8.11M shares derived: average of 4 quarters · filed 2016-02-26 | |||
| 2013-12-31 | 3.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 3.68M shares derived: average of 2 quarters · filed 2016-02-26 | 3.62M shares derived: average of 3 quarters · filed 2016-02-26 | 3.58M shares 10-K · filed 2016-02-26 | |||
| 2013-09-30 | 3.62M shares 10-Q · filed 2014-11-10 | 3.56M shares derived: average of 2 quarters · filed 2014-11-10 | 3.53M shares 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | 3.50M shares 10-Q · filed 2014-08-11 | 3.48M shares 10-Q · filed 2014-08-11 | |||||
| 2013-03-31 | 3.46M shares 10-Q · filed 2014-05-12 | ||||||
| 2012-12-31 | 3.12M shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |